Merrimack Pharmaceuticals... (MACK)
NASDAQ: MACK
· Real-Time Price · USD
15.14
0.01 (0.07%)
At close: May 17, 2024, 9:59 PM
Merrimack Pharmaceuticals Revenue
Merrimack Pharmaceuticals reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2024, Merrimack Pharmaceuticals generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
n/a
Employees
0
Market Cap
223.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | -100.00% |
| Dec 31, 2016 | 144.27M | +61.64% |
| Dec 31, 2015 | 89.26M | -13.14% |
| Dec 31, 2014 | 102.76M | +115.03% |
| Dec 31, 2013 | 47.79M | -2.32% |
| Dec 31, 2012 | 48.92M | +42.98% |
| Dec 31, 2011 | 34.22M | +68.51% |
| Dec 31, 2010 | 20.3M | +845.30% |
| Dec 31, 2009 | 2.15M | n/a |